← Back to Clinical Trials
Recruiting NCT05963737

NCT05963737 PMI Guide PS Setting in Pressure Support-ventilated Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05963737
Status Recruiting
Phase
Sponsor Capital Medical University
Condition Mechanical Ventilation
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2023-08-01
Primary Completion 2025-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
PS setting strategy in pressure-support ventilated patients

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2023-08-01 with a primary completion date of 2025-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Pressure support ventilation (PSV) is an assistant mechanical ventilation mode, that is widely implemented in mechanical ventilation treatment but there are no exact guidelines to guide PS setting. Traditional PS setting strategy (VT/PBW 6-8ml/kg and RR 20-30 breaths/min)has risks of excessive or insufficient assistance. Inspiratory muscle pressure index (PMI) is a noninvasive respiratory mechanical indicator and is available at the bedside. PMI was correlated with inspiratory effort and has the potential ability to predict low inspiratory effort and high inspiratory effort. The primary objective of this study is to investigate the clinical validity of a PMI-guided PS setting strategy. Specifically, the investigators aim to evaluate its impact on inspiratory effort as well as its potential for lung and diaphragm protection. Additionally, the investigators seek to assess the effect of this ventilation strategy on mechanical ventilation outcomes while evaluating the feasibility of our trial protocol.

Eligibility Criteria

Inclusion Criteria: * Patients under PSV * Predicted ventilated time of more than 48 hours. Exclusion Criteria: * Age less than 18 years old; * Known pregnancy; * BMI\>35kg/m2; * Brain-stem or cervical cord injury; * Known or clinically suspected elevated intracranial pressure (ICP\>18 mmHg); * Nervus phrenicus or diaphragm injury; * Broncho-pleural fistula; * Chronic obstructive pulmonary disease (COPD); * Pressure support ventilated time more than 48 hours before randomization.

Frequently Asked Questions

Who can join the NCT05963737 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Mechanical Ventilation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05963737 currently recruiting?

Yes, NCT05963737 is actively recruiting participants. Visit ClinicalTrials.gov or contact Capital Medical University to inquire about joining.

Where is the NCT05963737 trial being conducted?

This trial is being conducted at Beijing, China.

Who is sponsoring the NCT05963737 clinical trial?

NCT05963737 is sponsored by Capital Medical University. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology